One serious complication of chemotherapy is the reduced neutrophil count 7 to 12 days post-treatment. Severe neutropenia is characterized by...
Around 160 million women worldwide use intrauterine devices (IUDs), according to an estimate from 2019. IUD is a T-shaped device...
Acute lymphoblastic leukemia (ALL) is a blood and bone marrow cancer occurring due to the abnormal proliferation of immature lymphocytes...
Biliary tract cancer (BTC) is a form of gastrointestinal cancer that occurs in the bile duct, gallbladder, and ampulla of...
The FDA approved the Investigational New Drug application for initiating a Phase 1/2 clinical study of YH001 in combination with...
The FDA has granted breakthrough therapy designation to the ROS1 inhibitor taletrectinib for the treatment of patients with advanced or...
The FDA has granted approval for pemigatinib (Pemazyre) to treat adult patients with relapsed or refractory myeloid/lymphoid neoplasms (MLNs) and...
Pediatric patients aged 1 year and above with chronic graft-versus-host disease (cGVHD) can now benefit from ibrutinib following the FDA...
Novartis announced its intention to separate its generics and biosimilar division, Sandoz, into a new publicly traded standalone company through...
A new hope is looming for Myelofibrosis patients who experienced a suboptimal response to ruxolitinib and those who were JAK...
